Table 1. Comparison of demographic and clinical information between the patients undergoing surgery pre and post-implementation of the VTE prophylaxis guidelines.
| Characteristic | Pre-implementation (n=300) | Post-implementation (n=334) | p-value |
|---|---|---|---|
|
| |||
| Age at diagnosis (years): | |||
| Mean (SD*) | 58 (13.5) | 57 (12) | 0.175 |
| Median (Range) | 60 (20-88) | 58 (20-85) | |
|
| |||
| Body mass index (kg/m2): | |||
| Mean (SD) | 29.5 (8.7) | 30.1 (7.8) | 0.076 |
| Median (Range) | 27.4 (15.6-62.9) | 28.8 (16.0-63.4) | |
|
| |||
| Cancer type (N (%)): | |||
| Ovary | 151 (50.3%) | 203 (60.8%) | 0.010 |
| Uterine | 112 (37.3%) | 89 (26.6%) | |
| Cervix | 32 (10.7%) | 30 (9.0%) | |
| Vagina/Vulva | 5 (1.7%) | 12 (3.6%) | |
|
| |||
| Anesthesia time (minutes): | |||
| Mean (SD) | 286 (121) | 310 (140) | 0.009 |
| Median (Range) | 263 (78-827) | 289 (74-1099) | |
|
| |||
| Length of stay (days): | |||
| Mean (SD) | 8 (6) | 7 (4) | 0.002 |
| Median (Range) | 5 (1-50) | 6 (2-31) | |
|
| |||
| Estimated blood loss (ml): | |||
| Mean (SD) | 523 (603) | 466 (513) | 0.230 |
| Median (Range) | 350 (10-5000) | 300 (10-4500) | |
*
SD: standard deviation